The MifeMiso trial
a randomised, double-blind, placebo-controlled trial - The Lancet
MifeMiso was a multicentre, parallel-group, double-blind, placebo-controlled randomised effectiveness trial in 28 hospitals across the UK. Women ...
The MifeMiso trial - The Miscarriage Association
Find out about the MifeMiso trial, which is looking at whether a single drug treatment (misoprostol) or a combination of drug treatments (mifepristone plus ...
a randomised, double-blind, placebo-controlled trial - PubMed
Findings: Between Oct 3, 2017, and July 22, 2019, 2595 women were identified as being eligible for the MifeMiso trial. 711 women were ...
Introduction - Mifepristone and misoprostol versus placebo ... - NCBI
A trial comparing MifeMiso to misoprostol alone for the medical management of missed miscarriage was required because: NICE guideline CG154 called for a ...
MifeMiso: Mifepristone and misoprostol for the medical management ...
Researchers from the Tommy's National Centre for Miscarriage Research took part in the MifeMiso trial, which was designed to increase the evidence available ...
a randomised, double - The Lancet
Methods MifeMiso was a multicentre, double-blind, placebo-controlled, randomised trial in 28 UK hospitals. Women were eligible for enrolment if ...
MifeMiso trial - University of Birmingham
Primary clinical objective: To test the hypothesis that treatment with mifepristone plus misoprostol is superior to misoprostol alone for the resolution of ...
The MifeMiso Trial: guidelines for management of missed ... - Tommy's
The MifeMiso trial. The MifeMiso trial, published in the Lancet, was carried out at Tommy's National Centre for Miscarriage Research and aimed ...
MifeMiso - Health Research Authority
This study will focus on women whose pregnancy sac remains inside the womb (known as a missed miscarriage) and opt for medical management of their miscarriage ...
the MifeMiso RCT - NIHR Journals Library
This trial showed that giving mifepristone in addition to misoprostol was superior for resolution of missed miscarriage within 7 days by medical management.
Cost‐effectiveness of mifepristone and misoprostol versus ...
The MifeMiso trial is a multicentre, double-blinded, placebo-controlled, randomised trial. Details of the trial design and results are published ...
a randomised, double-blind, placebo-controlled trial
MifeMiso was a multicentre, double-blind, placebo-controlled, randomised trial in 28 UK hospitals. Women were eligible for enrolment if they were aged 16 years ...
MifeMiso RCT results: Mifepristone Plus Misoprostol or Misoprostol ...
... (MifeMiso) Trial. Participants. ≥16 years. Missed miscarriage ... Masking: Participants, clinicians, pharmacists, trial nurses, and midwives masked ...
Emma's experience - The Miscarriage Association
Emma took part in the MifeMiso trial. She shares her experience and reflections here. After having two healthy pregnancies, I was shocked and very distressed.
... trial of mifepristone and misoprostol versus misoprostol alone in the medical management of missed miscarriage: The MIFEMISO trial, award_amount=1684235.4 ...
Cost‐effectiveness of mifepristone and misoprostol versus ...
... evaluation based on the MifeMiso trial. CB Okeke Ogwulu,. CB Okeke Ogwulu. Health Economics Unit, Institute of Applied Health Research, College ...
About the MifeMiso trial - University of Birmingham
A randomised placebo-controlled trial of mifepristone and misoprostol versus misoprostol alone in the medical management of missed miscarriage.
MifeMiso: medical management of missed miscarriage - YouTube
The drug misoprostol for the treatment of missed miscarriage, but without strong evidence. This trial was designed to find out whether ...
The MifeMiso RCT (2021) - Shrewsbury and Telford Health Libraries
A withintrial cost-effectiveness study and a nested qualitative study were also conducted as part of the trial. Results A total of 711 women ...
a randomised, double-blind, placebo-controlled trial
Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo- ...